Form 4 Filing for Malik Fady Ibraham - CYTOKINETICS INC

On June 23, 2026, Fady Ibraham Malik, EVP Research & Development at CYTOKINETICS INC, reported several transactions involving the company's common stock. Malik acquired 3,500 shares of common stock at a price of $7.80 per share, increasing his post-transaction holdings to 157,402 shares. Concurrently, he disposed of 3,500 shares of common stock at a price of $79.51 per share, resulting in 153,902 shares remaining. Additionally, Malik exercised a non-qualified stock option to acquire 3,500 shares of common stock, with an exercise price of $7.80 per share. This transaction resulted in his post-transaction holdings of options being 40,886. The transactions were reported on a Form 4 filing.